North America Cell Based Assay Market – Growth & Forecast (2024 – 2032)

Cell-based assays consists a variety of assays that measure cellular parameters such as proliferation, cell toxicity, production of markers, motility, activation of specific signalling pathways and changes in morphology. The cell-based assay market is driven by the increased adoption of high throughput screening methods, increasing investments in drug discovery, increase in the cell-based research activities, rapid technological advances, non-invasive methods of monitoring and the development in the automation.

North America Cell-Based Assay Market Segments Size & Growth:

North America Cell-Based Assay Market is expected to increase by an $ XX billion by 2024 at a CAGR of XX% Increasing research activities in drug discovery, rise in demand for biological drugs, technological advancement, government expenditure, growing need for toxicity screening in drugs are expected to fuel the market for cell-based assays. However, need to reduce the cost associated the drugs, and technical advancements in innovations are expected to drive the market growth. Cell-based assay market is restrained by the lack of skilled personnel and high on maintenance and operational costs.

North America Cell-Based Assay Market Segments Share:

North America Cell-Based Assay market is segmented into the type of products which includes cell lines, ligands & Inhibitors and cell culture kits, reagents & consumers. Among these cell lines holds the most significant share due to the presence of different varieties of cell lines. Based on the technology, North America cell-based assay market flow cytometry, high content screening, label-free detection and others. Application segment includes drug discovery and ADME Research and others. Adoption of high throughput screening methods and increase in the ADME research investments expected to fuel the market growth.

Based on end-user cell-based assay approach is further subdivided into biotechnology, pharmaceuticals, academia and CRO. Based on geography, North America holds the most significant share in the global cell-based assay market due to the growing availability of funds for research and resilient drug discovery activities in the countries like the US.

North America Cell-Based Assay Market Trends:

• Mammography system was launched by the GE healthcare that allows patients to control their compression by remote control.
• NanoBRET target engagement intracellular kinase assay was launched by the Promega to demonstrate the potency and selectivity of kinase inhibitors in living cells.
• Volar Glass new packaging line getting manufactured by the Corning by Governor Cuomo.
• AMETEK, Inc acquired creaform Inc a leading manufacturer and developer of innovative portable 3D measurement technologies.

North America Cell-Based Assay Market Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

• Ametek, Inc
• Promega Corporation
• GE Healthcare
• Corning, Inc
• Bio-Rad Laboratories